BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Direct acting antivirals
1
Generic vs brand forms of direct acting antivirals for hepatitis C virus treatment in Egyptian children
12/26/2025 10:27:29 AM | Browse: 55 | Download: 279
2
Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time?
6/14/2024 8:01:41 AM | Browse: 119 | Download: 445
3
Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?
5/22/2024 11:33:24 AM | Browse: 213 | Download: 766
4
Serum omentin-1 is correlated with the severity of liver disease in patients with chronic hepatitis C
12/25/2023 6:03:15 AM | Browse: 253 | Download: 1519
5
Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report
10/25/2023 8:49:11 AM | Browse: 353 | Download: 1153
6
Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C
12/2/2022 12:50:19 PM | Browse: 542 | Download: 1738
7
Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
6/23/2022 2:39:01 PM | Browse: 636 | Download: 1698
8
Breakthroughs and challenges in the management of pediatric viral hepatitis
5/20/2021 8:38:05 AM | Browse: 722 | Download: 1775
9
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
10/12/2018 5:32:21 AM | Browse: 1659 | Download: 2056
10
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
6/28/2018 2:47:35 AM | Browse: 1376 | Download: 1990
11
Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
3/26/2018 8:48:04 AM | Browse: 1348 | Download: 2599
12
Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?
3/4/2018 12:36:47 PM | Browse: 1104 | Download: 1974
13
Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1
12/27/2017 10:31:19 AM | Browse: 1328 | Download: 2700
14
Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome
7/5/2017 4:40:08 AM | Browse: 1218 | Download: 2382
15
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
3/6/2017 3:54:00 PM | Browse: 1600 | Download: 2344
16
Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment
2/26/2017 6:20:00 PM | Browse: 1356 | Download: 1938
17
Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
11/4/2016 10:35:00 AM | Browse: 1392 | Download: 2763
18
Hepatitis C virus: A time for decisions. Who should be treated and when?
1/29/2016 11:06:00 AM | Browse: 1261 | Download: 2846
19
Treatment strategies for chronic hepatitis C prior to and following liver transplantation
1/7/2016 12:14:00 PM | Browse: 1258 | Download: 2058
20
Hepatitis C genotype 4: The past, present, and future
12/4/2015 3:24:00 PM | Browse: 2068 | Download: 2872
21
Era of direct acting antivirals in chronic hepatitis C: Who will benefit?
10/30/2015 11:57:00 AM | Browse: 1712 | Download: 2314
22
Predictive factors associated with hepatitis C antiviral therapy response
6/29/2015 5:40:00 PM | Browse: 1375 | Download: 2336
23
Hepatitis C virus: Virology, diagnosis and treatment
6/3/2015 12:01:00 PM | Browse: 1757 | Download: 2425
24
Hepatitis C: New challenges in liver transplantation
5/20/2015 5:01:00 PM | Browse: 1293 | Download: 2689
25
Impact of all oral anti-hepatitis C virus therapy: A meta-analysis
4/19/2015 5:46:00 PM | Browse: 1263 | Download: 2153
26
Management of patients with hepatitis C infection and renal disease
2/13/2015 9:30:00 AM | Browse: 1556 | Download: 1619
27
Complementary and alternative medications in hepatitis C infection
9/10/2014 6:38:00 PM | Browse: 1260 | Download: 1198